ROCA, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 6.126
AS - Asia 2.440
EU - Europa 1.750
SA - Sud America 519
Continente sconosciuto - Info sul continente non disponibili 165
AF - Africa 46
OC - Oceania 7
Totale 11.053
Nazione #
US - Stati Uniti d'America 5.988
SG - Singapore 852
CN - Cina 831
BR - Brasile 429
UA - Ucraina 380
DE - Germania 342
HK - Hong Kong 285
IT - Italia 237
VN - Vietnam 191
GB - Regno Unito 149
RU - Federazione Russa 128
FR - Francia 108
FI - Finlandia 106
TR - Turchia 87
IE - Irlanda 80
CA - Canada 71
PL - Polonia 68
IN - India 44
AR - Argentina 38
CZ - Repubblica Ceca 36
BD - Bangladesh 35
IQ - Iraq 22
BE - Belgio 20
MX - Messico 20
SE - Svezia 20
JP - Giappone 18
NL - Olanda 18
EC - Ecuador 16
ES - Italia 16
CO - Colombia 12
ID - Indonesia 11
SA - Arabia Saudita 11
ZA - Sudafrica 11
AT - Austria 9
VE - Venezuela 9
CR - Costa Rica 8
MA - Marocco 8
DZ - Algeria 7
SV - El Salvador 7
UZ - Uzbekistan 7
AU - Australia 6
JM - Giamaica 6
PY - Paraguay 6
HN - Honduras 5
IR - Iran 5
LT - Lituania 5
AZ - Azerbaigian 4
CL - Cile 4
CW - ???statistics.table.value.countryCode.CW??? 4
EG - Egitto 4
EU - Europa 4
GP - Guadalupe 4
PK - Pakistan 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
BG - Bulgaria 3
CH - Svizzera 3
DK - Danimarca 3
EE - Estonia 3
IL - Israele 3
NI - Nicaragua 3
NP - Nepal 3
RO - Romania 3
AL - Albania 2
AM - Armenia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KE - Kenya 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MU - Mauritius 2
MY - Malesia 2
PH - Filippine 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
ET - Etiopia 1
IS - Islanda 1
JO - Giordania 1
KW - Kuwait 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LY - Libia 1
ML - Mali 1
MZ - Mozambico 1
NA - Namibia 1
Totale 10.888
Città #
Fairfield 755
Ashburn 587
Singapore 433
Woodbridge 391
Jacksonville 316
Houston 314
Seattle 291
Hong Kong 281
Cambridge 257
San Jose 250
Wilmington 248
Beijing 215
Chandler 202
Ann Arbor 179
The Dalles 151
Princeton 146
Council Bluffs 144
New York 121
Nanjing 102
Los Angeles 96
Helsinki 84
Dublin 79
Istanbul 71
Warsaw 66
Dearborn 64
Lauterbourg 64
Ho Chi Minh City 59
Munich 55
São Paulo 51
Chicago 47
Dallas 47
Des Moines 42
Santa Clara 41
San Francisco 37
Changsha 36
Nanchang 36
Hanoi 34
Moscow 33
San Diego 30
Shanghai 30
Hebei 29
Brescia 28
Redondo Beach 27
Buffalo 26
London 25
Orem 25
Shenyang 25
Toronto 23
Brno 22
Atlanta 21
Brooklyn 21
North Bergen 21
Boardman 20
Denver 20
Montreal 20
Brussels 19
Jinan 19
Turku 19
San Mateo 18
Milan 17
Tianjin 16
Boston 15
Tokyo 15
Olomouc 14
Rio de Janeiro 13
Zhengzhou 13
Jiaxing 12
Nürnberg 12
Rome 12
Belo Horizonte 11
Kunming 11
Poplar 11
Stockholm 11
Dhaka 10
Dong Ket 10
Frankfurt am Main 10
Washington 10
Columbus 9
Genoa 9
Guangzhou 9
Hangzhou 9
Phoenix 9
Amsterdam 8
Falls Church 8
Lanzhou 8
Mexico City 8
Mumbai 8
Ningbo 8
Nuremberg 8
Taizhou 8
Augusta 7
Charlotte 7
Chennai 7
Da Nang 7
Jeddah 7
Lancaster 7
Manchester 7
San José 7
San Salvador 7
Baghdad 6
Totale 7.314
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 299
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case 244
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 221
Acute functional reactivation of the language network during awake intraoperative brain mapping 219
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 219
Effects of CPAP on systemic hypertension in OSAH: a monocentric, observational, cohort study 212
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 212
Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy 211
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 209
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 203
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 203
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 203
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 202
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 197
Palbociclib inhibits proliferation of human adrenocortical tumor cells 196
Regression of advanced neuroendocrine tumors among patients receiving placebo 194
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 193
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 189
Osimertinib in EGFR Mutation–Positive Advanced NSCLC 181
Detection of serum proteomic profile predictive for epidermal growth factor receptor tyrosine kinase inihibitors (EGFR-TKIs) in 1st line chemotherapy responders 181
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 180
CT texture analysis as predictive factor in metastatic lung adenocarcinoma treated with tyrosine kinase inhibitors (TKIs) 180
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 179
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis 178
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) 178
Tumor Infiltrating Neutrophils Are Enriched in Basal-Type Urothelial Bladder Cancer 178
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations 177
Serum vitamin D and prostate cancer prognosis: The story continues 174
When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors? 174
Positive FDG-PET/CT of the pleura twenty years after talc pleurodesis: three cases of benign talcoma 168
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 168
How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension 163
Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies 161
Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient 158
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 157
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 156
Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: Prediction of the response to the first-line chemotherapy 155
IFN-α in advanced well-differentiated neuroendocrine tumors: The neglected drug? 152
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions 151
Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study 150
Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions 148
Echocardiographic evaluation in subjects with (1)-Antitrypsin deficiency 143
Listening understanding and acting (lung): Focus on communicational issue in thoracic oncology 143
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 139
CT scanner for the pleural staging of pleural cancer: How accurate is this? 135
Malignant pleural mesothelioma: from the bench to the bedside 129
CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer 128
Rate of venous thromboembolism and atrial fibrillation in a real-world case series of advanced cancer patients: the CaTEV Study 127
THE ASSOCIATION BETWEEN PROTEOMIC PROFILE DETECTED BEFORE 2ND/3RD LINE EGFR-TKIS AND RESPONSE TO 1ST LINE CHEMOTHERAPY 125
Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It? 125
18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enough 119
Efficacy of topic steroids in the management of asthma and chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients during treatment with nivolumab 118
Onde elettromagnetiche ad alta frequenza e bassa intensit. nel trattamento delle ulcere cutanee: 8 casi clinici. 117
False Negative Pleural Cytology in Patient with Malignant Pleurisies: Is Pleural EpCAM-Positive Microparticles a Complementary Tool for Diagnosis? 115
Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions 114
ASTRIS, a real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC): preliminary analysis of the Italian cohort 114
Malignant pleural mesothelioma signs and symptoms 108
Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis 102
Pathologie pleurale 101
IMPACT OF CLINICAL PARAMETERS ON OUTCOME OF PATIENTS TREATED WITH GAMMA KNIFE STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER 98
Maintenance with Lanreotide in SCLC Patients, Expressing Somatostatine Receptors, after Response to First Line Therapy 96
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 85
The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluation 84
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis 84
EGFR, KRAS, HER2, BRAF and PI3KCA mutation status in metastatic cancer patients: Thoracic cytological specimens obtained in routine clinical practice 82
Thoracic Cytological Specimens Obtained In Routine Clinical Practice And EGFR, Kras, Her2, Braf And Pi3kca Mutation Status In Metastatic Cancer Patients 78
Multigene mutation analysis of mediastinal and hilar lymph nodes sampled by endobronchial unltrasound-guided needle aspiration 77
PROTEOMIC SIGNATURE TO IMPROVE OUTCOME IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH EGFR-TKIS 76
Multigene Mutation Analysis Of Mediastinal Lymph Nodes Assessed By Endobronchial Ultrasound-Guided Needle Aspiration: A Prospective Study 75
Onde elettromagnetiche ad alta frequenza e bassa intensità nel trattamento delle ulcere cutanee: 8 casi clinici 74
Tissue factor positive microparticles remain undetectable by flow cytometry in pleural fluids from cancer patients despite high level of procoagulant activity 73
Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial 71
Is DNA repair a potential target for effective therapies against malignant mesothelioma? 66
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study 59
Totale 11.053
Categoria #
all - tutte 52.591
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.591


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022455 0 0 0 45 9 36 21 63 25 72 47 137
2022/2023589 85 24 16 44 53 130 3 74 105 1 24 30
2023/2024618 47 22 63 34 33 91 19 21 154 9 6 119
2024/20251.323 20 5 8 199 145 93 117 53 183 74 259 167
2025/20262.744 262 440 240 426 321 175 331 77 150 204 96 22
2026/2027826 66 116 191 453 0 0 0 0 0 0 0 0
Totale 11.053